v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenues:        
Product revenue, net $ 431,268 $ 287,268 $ 1,106,857 $ 637,320
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Product [Member] Product [Member] Product [Member] Product [Member]
Operating expenses:        
Cost of sales $ 37,815 $ 18,122 $ 104,669 $ 31,700
Research and development 71,755 174,004 271,625 272,257
Selling, general and administrative 265,709 209,117 823,605 573,851
Total operating expenses 375,279 401,243 1,199,899 877,808
Income (loss) from operations 55,989 (113,975) (93,042) (240,488)
Interest income 8,239 10,308 23,586 27,905
Interest expense (8,069) (7,451) (23,828) (14,012)
Loss on extinguishment of debt 0 (2,779) 0 (2,779)
Other expense, net (717) (293) (3,604) (335)
Net income (loss) $ 55,442 $ (114,190) $ (96,888) $ (229,709)
Net income (loss) per common, Series A preferred and Series B preferred share:        
Net income (loss) per common, Series A preferred, and Series B preferred share - basic (in dollars per share) $ 1.90 $ (4.01) $ (3.32) $ (8.12)
Net income (loss) per common, Series A preferred, and Series B preferred share - diluted (in dollars per share) $ 1.83 $ (4.01) $ (3.32) $ (8.12)
Weighted average number of shares outstanding - basic (Note 13) (in shares) 29,247,673 28,508,089 29,142,570 28,276,865
Weighted average number of shares outstanding - diluted (Note 13) (in shares) 30,313,137 28,508,089 29,142,570 28,276,865